A multi-centre, double-blind, placebo-controlled, multiple-dose crossover proof of concept study to compare the efficacy of mefenamic acid administered vaginally and orally in healthy menstruating women with primary dysmenorrhoea requiring analgesia

Trial Profile

A multi-centre, double-blind, placebo-controlled, multiple-dose crossover proof of concept study to compare the efficacy of mefenamic acid administered vaginally and orally in healthy menstruating women with primary dysmenorrhoea requiring analgesia

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Jul 2017

At a glance

  • Drugs Mefenamic acid; Mefenamic acid
  • Indications Dysmenorrhoea
  • Focus Therapeutic Use
  • Sponsors Plethora Solutions
  • Most Recent Events

    • 05 Mar 2015 Planned number of patients changed from 159 to 105 according to ISRCTN: Current Controlled Trials.
    • 19 Apr 2012 Actual end date (7 Jul 2008) added as reported by European Clinical Trials Database.
    • 19 Apr 2012 Status changed from active, no longer recruiting to completed as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top